HB0017 binds to IL-17A with high specificity and affinity at the physiological interface with IL-17RA. It then effectively antagonises the functions of IL-17A to inhibit psoriasis-like inflammation. This may facilitate reduction in IL-17-induced inflammation [216,217]. This evidence concerns the gene IL17A and psoriasis.